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MILTON, J. G., W. YlING, C. GLlISHAK, and M. M. FROJMOVIC. 1980. Kinetics of ADP-induced human platelet shape change:
apparent positive cooperativity. Can. J. Physiol. Pharmacol. 58, 45-52.
The kinetics of ADP-induced human platelet shape change have been examined. Initial velocities of platelet shape change
were estimated by two methods: ( 1) the slope of the initial decrease in light transmission through stirred, citrated platelet-rich
plasma. and (2) direct examination of platelet morphologies by phase-contrast microscopy. In both cases, a value of the Hill
coefficient, Nit. significantly greater than 1 is obtained (2.0 ± 0.2 and 1.8 ± 0.2, respectively). The observed elevated value
of Nit is not due to a substantial fraction of the ADP being platelet bound, the presence of factors in the plasma, platelet
heterogeneity, or the influence of the rate of platelet shape change reversion. Our observations suggest that ADP-induced platelet
shape change may be a positively cooperative or "thresh.old" type response.
MILTON, J. G., W. YUNG, C. GLUSHAK et M. M. FROJMOVIC 1980. Kinetics of ADP-induced human platelet shape change:
apparent positive cooperativity. Can. J. Physiol. Pharmacal. 58,45-52.
On etudie la cinetique du changement de fonne des plaquettes humaines induit par de l' ADP. Les vitesses initiales du
changement de forme des plaquettes sont esrimees selon deux methodes: ( J) la pente de la diminution initiale de la transmission
de la lumiere a travers du plasma agite. citrate et riche en plaquettes, et (2) l'examen direct de la morphologie des plaquettes
par microscopie it contraste de phase. On obrient dans les deux cas une valeur du coefficient de Hill, Nth qui est plus grande
que celie normalement obtenue (2.0 ± 0.2 et 1.8 ± 0.2, respectivement). La valeur elevee de Nit qui est observe n'est pas due
a une fraction substantielle d'ADP qui senut tiee aux plaquettes, pas plus qu'a la presence de facteurs dans Ie plasma, a
l'heterogeneite des plaquettes ou a I'influence du taux de reversion du changement de forme des plaquettes. Nos observations
suggerent que Ie changement de forme des plaquettes induit par de l' ADP pouITait constituer une reponse positivement cooperative ou de type "a seuil."
lTraduit par Ie journal]

Introduction
Platelet shape change from smooth, discoid-shaped
platelets (discocytes) to more spherical forms with pseudopodal projections (echinocytes) induced by adenosine
diphosphate (ADP) is generally regarded as an example
of a receptor-mediated process (Born 1965, 1970; Born
and Feinberg 1975; Mills and Macfarlane 1975; Nachman and Ferris 1974). Recently, Bennett et al. (1978)
have demonstrated that the ADP receptor for shape
change may be a membrane polypeptide of 100 000
molecular weight. The nature of the mechanism by
which the binding of ADP molecules to membranebound receptors is translated into the morphological
event of shape change is not precisely known.
The basis for present day discussions of the action of
molecules at the receptor level is formed by models first
introduced by Clark (1926) which closely resemble
those used to describe the interaction of an enzyme with
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(MRCC) (grant MA-3612) and a FCAC grmt from the Quebec
Education Department.
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its substrate. In view of these considerations, the kinetics of ADP-induced platelet shape change can be described in terms of a ,. Michaelis - Menton-like" model:

(1]

ADP

+

k.
ka
R ;;:=: ADP-R ~ echinocyte
k2

where k .. k 2 , and k 3 are rate constants, R is a receptor
for platelet shape change located on a discocyte,
ADP-R is the ADP-receptor complex, and the symbol
, ''''''''-+'' indicates that the conversion of discocyte to
echinocyte may involve additional steps subsequent to
the binding of ADP to its receptor, to yield

Vmax (ADP]f
[2]

V
K'

+

[ADP]f

where V and Vmax are, respectively, the initial and
maximal initial velocities for shape change, [ADPlr is
the concentration of free ADP, i.e., that which is not
receptor bound, and K' is the apparent
Michaelis-Menton constant obtained from the x-intercept of a plot of V-I versus [ADP]f-l.
Previous studies with rabbit (Born 1970) and human
(Favis and Colman 1978) platelets have suggested that
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the kinetics of ADP-induced platelet shape change are
consistent with that predicted by Eq. 2. However, the
lowest value of V considered in these studies corresponded to only approximately 30% of Vmax' Departures
from the description offered by Eq. 2 are anticipated to
be most significant at low [ADP], i.e., low V. Moreover, the changes in light transmission utilized by these
authors to estimate V may not accurately reflect the rate
of platelet shape change, as, for example, changes in
platelet refractive index will also affect light transmission (Frojmovic 1978). It is clearly necessary to try to
extend the kinetic measurements of shape change to
lower values of V with a more direct measure of shape
change before any conclusions concerning the nature of
the process can be safely drawn.
Here we directly measure V by examining changes
in platelet morphology with phase-contrast microscopy.
The results are compared with those when V is measured from changes in light transmission. In both cases,
it is shown that over a range of [ADP] which extends
the measurement of V from Vmax to approximately 10%
of Vmax' Eq. 2 does not provide an adequate description
of the kinetics of ADP-induced platelet shape change.
A Hill plot, i.e. log (V!(Vmax - V» versus log ( [ADP] ),
is performed. Whereas Eq. 2 predicts that the Hill coefficient, N H, equals I, our data yield N H > 1. The significance of this observation is discussed.
Methods
Preparation of platelet-rich plasma (PRP). platelet-free
plasma (PFP). and washed platelets
Normal donors were chosen from healthy men and women
between the ages of 20 and 30 years. Blood was drawn by
venipuncture into 3.8% citrate (one volume to nine volumes
blood) at 37°C and PRP prepared as described previously
(Tang and Frojmovic 1977). PFP was prepared by first centrifuging PRP for 15 min at 1900 x g, 25°C, and then centrifuging the supernatant at 30000 x g, 4°C, for 15 min. PFP
was allowed to incubate at 37°C for an additional 30 min before
use to remove residual ADP. Washed platelets were prepared
by the method of Mustard et al. (1972) and were generously
supplied by Dr. H. L. Goldsmith, McGill University.
Kinetic studies
ADP (Sigma Chemical Co.) was dissolved in Ca+ 2-Mg+2free Tyrodes buffer. One to 10 ILL ADP was quickly injected
using a Hamilton syringe into 0.4 mL platelet suspension
which was contained in a siliconized cuvette (6.9 mm x 45
mm) with stir bars (6 mm x 1 mm) spun at 1000 rpm, 37°C.
Injection of the dye, azure A, indicated that under these conditions mixing was complete in less than 1 s. The initial velocity of shape changes, V, was estimated by the following
two methods.
(a) Changes in light transmission
Changes in light transmission weremonitored using the aggregometer apparatus described previously (Frojmovic 1973),
using a rapid chart speed (10 inches/min; I inch = 25.4 mm).
A rapid decrease in light transmission is observed following
the addition of ADP to stirred PRP. The slope of the initial

decrease in light transmission was utilized as a measure of V.
Several other authors (Born 1970; Favis and Colman 1978;
Bennett et aI. 1978) have utilized this measurement to estimate
V.

(b) Phase-contrast microscopy
At 5 s following the addition of ADP to stirred PRP, 0.05mL samples were withdrawn and fixed with four volumes of
1.3% glutaraldehyde at 37°C as described previously
(Frojmovic and Panjwani 1976; Milton and Frojmovic 1979).
This sampling time was chosen as it was found that for all
[ADP]' s used in this study, the increase in the fraction of
shape-changed platelets,!.:, was linear for at least the first 6 s
following ADP addition (Fig. 1). The value of It; measured
at 5 s following ADP addition was taken as a measure of V.
Shape-changed platelets were identified with phase-contrast
microscopy (Zeiss universal microscope; magnification x
800) as those which possessed at least one pseudopod and (or)
whose axial ratio, i.e., the ratio of thickness to diameter, exceeded 0.5 (Milton and Frojmovic 1979). A third criterion
which had to be used to identify platelets in the early stages
of shape change was the appearance of a rougher or "fuzzy"
cell outline under phase-contrast microscopy. This contrasted
with the very smooth outline of unactivated platelets. Darkfield microscopy observation indicated that the earlier stages
of platelet shape change were associated with the development
of short pseudopods and membrane undulations. Control experiments demonstrated that !.: was not altered by the above
fixation procedure. In determining !.:, at least 400 platelets
were randomly selected.
Platelet shape change reversion
The rate of platelet shape change reversion was estimated
as follows. Following the addition of ADP to stirred PRP, the
stirring was stopped after complete mixing had occurred to
prevent aggregation, 0.025-mL samples were removed as a
function of time and fixed with glutaraldehyde, and fE was
determined as described above.

r- 0.99
10.0 }lM

r.O.99
lO}lM

..!'

0.6

r .0.98

0.25}1M

0.2

2

3

5

6

Time after ADP addition (a)

FIG. 1. Fraction of shape-changed platelets (ft;) during the
first 6 s after ADP addition demonstrating the linearity with
time over the ADP concentration range used in this study.
Correlation coefficients (r) of the three corresponding linear
regression lines are shown. _, 10.0 JJM ADP; A, 1.0 JJM
ADP, e, 0.25 JJM ADP.
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Results
The results of a typical experiment showing the effect
of total ADP concentration, [ADP], on V as measured
by direct examination of platelet morphologies under
phase-contrast microscopy are given in Fig. 2A. Although over the concentration range of 0.25-10 IJM
ADP the plot of V-I versus [ADPl-1 is approximately
linear (see dotted line in Fig. 2B), a linear relationship
does not hold over the whole concentration range investigated. In particular, there is a pronounced upward
curvature as [ADP] becomes smaller. Qualitatively similar trends are observed when V is measured as the initial
slope of the decrease in light transmission (see Fig. 2 C
and D). This demonstrates that the results in Fig. 2 A
and B are not dependent on the method utilized to measure V. The observation that a plot of V-I versus
[ADP]-l is not linear demonstrates that the kinetic de-

1.0

scription implied by Eq. 2 does not provide a valid description for the kinetics of ADP-induced platelet shape
change.
Closer examination of the data presented in Fig. 2 A
and C suggests that the curves are sigmoid. Hill plots
for these data are shown in Fig. 3. In each case, N H is
significantly greater than 1 (P < 0.05). It is important
to note that the linear range ofthe Hill plots includes V's
measured in the more linear range of the plots in Fig.
2 B and D. N H and the concentration of ADP required
for 1/2 V max,[ADP]1/2' for a number of different donors
are summarized in Table 1.
A value of N H > 1 is suggestive of some kind of cooperative process or "threshold-type" response for ADPinduced platelet shape change. However there are other
possibilities which may result in a spurious departure
from Eq. 2.
t
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FIG. 2. Effect .of ADP concentration on the velocity ( V) of the change in shape of human platelets observed in a typical
experiment. Donor (donor 1) was female, age 22 years, platelet count 330 000 #o!-L-J, V has been measured by the light microscope (A) and by the light transmission (e) methods which are described in Methods. Double-reciprocal plots of these results
are given in (B) and (D), respectively. Error bars in (B) and (D) give the highest and lowest values measured, the point
corresponding to the mean of measurement~ made (usually 2 or 3). For the remaining points in (B) and (D), the deviations in
the measurements were less than the width of the point used in preparing the figure. K' detennined by extrapolating the dotted
line to V-I = 0 was 1.0 x 10-6 M (B) and 8.6 x 10-- 7 M (D). K' determined for a number of donors in this way was
summarized in the text of Discussion.
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TABLE

I. Comparison of [ADP]1/2 and N H for washed platelets and platelets in PRP when V
is measured by the light microscope and light transmission methods
Method used to measure V
Light microscope

Light transmission
[ADP]1/2
x 107 M

PRP
Donor I
Donor 2
Donor 3
Donor 4
Donor 5
. Donor 6
Donor 7
Donor 8
Mean values
Washed platelets
Donor 7
Donor 8
Donor 9
Mean values

6.4(8Y'

1.6(0.99Y'·'··"

4.4(5)
2.9(7)
4.1 (3)

2.0(0.99)
I. 9(0. 97Y'
1.7(0.99)

4.6(7)

2.0(0.99)

4.5± 1.3'>

1.2(6)

1.8±0.2'

I. 7(0. 97)U

Nil

4.7(8Y'
3.4(6)
5.1(6)

1.8(0.97y'.r.t1
2.0(0.90)
1.7(0.98)

4.7(6)

2. I (I.oof

3.3(10)

2.1(0.99)

4.6(10)
3.1(4)
4.1 ±0.8"

2.0(1.00)
2.3(1.00)
2.0±0.2'

1.8(9)
1.6(6)
1.6(7)
1.7±0.1

1.9(0.97)
2.5(0.94)
2. 2(0. 96)U
2.2±0.3

"The nwnber of data points falling in the linear range of the Hill plot is given in parentheses. In general only a single
measurement was made at each ADP concentration.
"The correlation coefficient for the points falling in the linear range of the Hill plot is given in parentheses.
'A I-test of the fonn IN_.=NH-l.O/S•• where S. is the siatKlard enor of the regression coetrlCient and I has N-2
degrees offreedom. was used to test if NH>I (Sokal and Rohlf 1969). In all cases. N H was signiflCatltly greater than I
(P < O.OS).
d An analysis of covariance (Sakal and Rohlf 1969) was utilized to establish that the values of N H determined by the
two methods were not signiflC8ntly different (0.25 < P < 0.50).
• A I-test was used to show that the mean [ADP1'11 values obtained by the two methods are not signifICantly different
(O.S < P < '0.9).
I A I-test was used to show that the mean N H values obtained by the two methods are not significantly different (0.1
<p < 0.2).
'The values of N H determined by the two methods were not significantly different. (0.1 < P < 0.25). Analysis same
as for footnote d.

(a) Fraction ofADP bound
In testing Eq. 2 by plotting V-I versus [ADP]-I, it
is implicitly assumed that the total ADP concentration,
[ADP], is approximately equal to [ADP]" Le., [ADP]
=[ADP],. An upward curvature for a plot of V-I versus
[ADPJ- 1 can occur when a large fraction (>25%) of the
ADP is platelet bound (Rodbard et al. 1974). A Hill plot
at a platelet count of 700 000 ILL - I is compared with
that obtained at a count of 40 000 ILL-I in Fig. 4. The
fact that N H is not significantly different at the two
platelet counts (0.1 < P < 0.25) strongly suggests that
only a negligible amount of the ADP is platelet bound
under the conditions of our experiment.
(b) Plasmafactors
N H and [ADP]1/2 for washed platelets and PRP are
compared in Table 1. As can be seen, N H remains elevated for washed platelets, but [ADP]1/2 is smaller. AI-

though these results indicate that the increased sensitivity of washed platelets to ADP may be related to the
absence of factors normally present in plasma, it is clear
that the elevated value of N H cannot be explained in
these terms.

1

(c) Platelet shape change reversion
Under appropriate conditions following ADP-induced
platelet shape change, human echinocytes revert spon- .
taneously back to discocytes (Ehrman et al. 1978). The
upward curvature shown in Fig. 2 B and D could be
explained by assuming that an increased contribution
from platelet shape change reversion lowers V at low
[ADP]. A plot of f.: versus time following ADP addition
when [ADP] is 0.5 and 0.1 p. M is shown in Fig. 5. The
former [ADP] corresponds to approximately K' and the
latter to a concentration which yields V on the upswing
portion of a plot of V- t versus [ADPt l (see Fig. 2B).
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FIG. 4. Comparison of Hill plots for ADP-induced platelet
shape change obtained at two different platelet concentrations
(donor 2, female). Nil for a platelet count of 700 000 ~L-I
was 1.98 and that for a platelet count of 40 000 ILL- I was 1.68.
An analysis of covariance as described in Sokal and Rohlf
(1969) was used to show that the slopes of these two Hill plots
are not significantly different (0.25 > P > 0.10). Solid line
is that obtained when the data are pooled; N H = 1.83.
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FIG. 3. Comparison of Hill plots for ADP-induced platelet
shape change when V is measured by the light microscope
method (A) and by the light transmission method (B). Data are
taken from Fig. I. In each case only the linear portion of the
Hill plot has been shown. An analysis of covariance as described in Sokal and Rohlf (1969) was used to show that the
slopes of these two Hill plots are not significantly different
(0.5 > P > 0.25).

If at a low [ADP] there is an increased contribution of
rate of platelet shape change reversion, then we would
expect to see that the time which corresponds to maximum iF. is shorter at the lower [ADP]. This expectation
is clearly not consistent with the data presented in Fig.
S. Therefore, the upward curvature of a plot of V-I versus (ADP]-l does not arise because of contributions due
to platelet shape change reversion. A more detailed analysis of the kinetics of platelet shape change reversion
will be presented in a separate communication (Milton,
J. G., Glushak, C., and Frojmovic, M. M.: in
preparation) .
Discussion
Our results demonstrate that the kinetics of ADPinduced platelet shape change cannot be adequately described by Eq. 2. In particular, our kinetic data yield a
value of N H > 1 whereas Eq. 2 predicts Nil = 1. Fur-

thermore, we have shown that the property N H > 1 is
not due to the influence of plasma-borne factors, nor to
a large fraction of ADP being platelet bound, nor to an
increased rate of platelet shape change reversion at low
[ADP). Karpatkin (1969a, I 969b) has demonstrated the
existence of subpopulations of platelets which differ
with respect to density, size, release reaction, and aggregation. However, binding sites of differing and independent affinities can only lead to N H < 1. 5 These
observations strongly indicate that the kinetics we are
observing reflect processes at the level of the platelet
ADP interaction leading to shape change. However, our
results do not specify the exact nature of the phenomena
at the level of the platelet ADP receptor which result in
an elevated N H'
At face value, N H > 1 suggests that ADP-induced
platelet shape change is a positively cooperative process. This can imply that the binding of an ADP mole~

Indeed when

[3]

V =

~

.Ii Vmax.[ADP]
,

[ADP] + K'I
where II is the fraction of receptors (platelets) with
distinct V maxl' K' h then it can be shown that
I

d2

(

~

)

/d (

[A~P])

2

< 0 for all positive/t, K'j,Vrnaxl '

Hence a plot ofy-I versus [ADP]-I will curve downwards.
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cule at one receptor site somehow increases the likelihood of binding of ADP molecules at other receptor
sites or that there is a cooperative enzymatic process
leading to shape change subsequent to the binding of
ADP to the receptor site. Positive cooperativity in membrane receptor mediated processes has been suggested
previously (Podleski 1973; Rodbard et aI. 1974; lard et
aI. 1975).
An elevated value of N H does not necessarily indicate
a positively cooperative process. A value of N H > 1 can
arise when there is a threshold or "all-or-none" type
response either at the level of binding to the receptor
(Dixon and Webb 1964) which can arise when the
binding of at least two molecules of ADP per receptor
site is required to initiate shape change or at the level
of the sequence of reactions subsequent to binding
which leads to shape change (Rodbard 1973; Goldstein
et aI. 1974).
Binding studies of ADP to isolated membranes
(Nachman and Ferris 1974) and intact platelets (Born
and Feinberg 1975) suggest that there is no positive
cooperativity at the level of the ADP-receptor binding.
This suggests that the apparent positive cooperativity
observed in our kinetic measurements arises at a step
subsequent to the binding of ADP to the receptor. Previous authors (Podleski 1973; Rodbard et aI. 1974) who
have observed positive cooperativity in membrane receptor mediated processes have also tended to conclude
that the cooperativity is due to processes subsequent to

the binding at the receptor. However, Bennett et aI.
(1978) have demonstrated that the number of "true"
ADP receptors, -2500 per platelet, is much smaller
than the number of receptors determined in the earlier
studies, e.g., 80 000 - 90 000 per platelet (Born and
Feinberg 1975) and 100 000 - 200 000 per platelet
(Nachman and Ferris 1974). It is possible that the presence of these additional receptors in the above binding
studies masked the cooperativity of the binding of ADP
to its "true" receptor. More careful binding studies will
be required before the question of the cooperativity of
the ADP-receptor binding process, or lack of, can be
answered.
Moyle et aI. (1976) have pointed out that an elevated
N H may also arise in a situation where there are "spare"
receptors, Le., when maximal response can be elicited
when only a small fraction (e.g., 1-2%) of the available
receptor sites aFe occupied. It is unlikely that the value
of N H > 1 observed here for ADP-induced platelet
shape change can be explained in these terms. Bennett
et al. (1978) observed that the maximal velocity of ADPinduced platelet shape change was decreased by the irreversible binding of the inhibitor, 5'- p-fluorosulfonyl
benzoyl adenosine, to the ADP receptor sites only after
at least 200 such binding sites were occupied by the inhibitor. As these authors estimated that there are -2500
"true" ADP receptor sites per intact platelet, this suggests that V max corresponds to greater than 90% occupancy of the receptor sites.

MILTON ET AI..

The kinetics of ADP-induced human and rabbit platelet shape change have been examined previously by light
transmission methods (Born 1970; Favis and Colman
1978). Although Favis and Colman (1978) do not report
a value of K' for ADP-induced human platelet shape
change, the value of K' which can be obtained from the
data presented in their communication, 4 x 10- 7 M, is
in excellent agreement with that obtained in our studies
from the linear regions of the plots of V-I versus
/ADPJ-' (corresponding to [ADP] ;;;. 4 x 10- 7 M), namely, 5.2 x 10- 7 ± 2.6 x 10- 7 (microscope, eight donors) and 4.2 x 10- 7 ± 1.1 x 10- 7 M (light transmission, six donors). It is of interest to note that closer
examination of the data presented by these authors with
emphasis placed on the values of V measured at low
[ADP'J suggested an upward curving V··! versus
[ADP]'" plot similar to that reported in this communication.
Although the two methods we have used to measure
V are in good agreement (compare, for example,
[ADP]1/2 in Table 1), it cannot be said that they agree
exactly. In particular, N H determined from light transmission data is typically slightly greater than that determined from data based on platelet morphologies (see
Table I). These differences may in part be due to the
relative sensitivity of the two techniques for detecting
platelet shape change. With the apparatus at our disposal
it was technically more difficult to measure the initial
slope of a small decrease in light trdnsmission as opposed to determining directly whether a fraction of
platelets have undergone shape change. A limitation of
light transmission measurements is that the presence of
pseudopods leads to a theoretically predicted increase
in light transmission, opposite from the decrease expected for shape change, which is normally associated
with pseudopod formation at the earliest stages of activation (Frojmovic 1978). On the other hand, the major
limitation of mea.<;uring V by direct microscopic observation of platelet morphologies is that it ultimately rests
on a subjective decision made on the part of the investigator. Our results do suggest that the differences in
kinetics observed between the two methods are small
enough that they can be used interchangeably for most
practical purposes, as, for example, determining
[ADP]1/2'
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anism for shape change should also provide an explanation for the observed kinetics of the process. It is anticipated that careful studies with the actual ADP
receptor molecule, possibly the 100 000 molecular
weight membrane polypeptide isolated by Bennett et al.
(1978), in light of the results reported here will greatly
facilitate the search of the mechanism for platelet shape
change.
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